Bourgeois Y - Search Results

1

Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.

Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF. Nemati F, et al. Among authors: bourgeois y. Clin Cancer Res. 2000 May;6(5):2075-86. Clin Cancer Res. 2000. PMID: 10815935

2

Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.

Némati F, Daniel C, Arvelo F, Legrier ME, Froget B, Livartowski A, Assayag F, Bourgeois Y, Poupon MF, Decaudin D. Némati F, et al. Among authors: bourgeois y. Anticancer Drugs. 2010 Jan;21(1):25-32. doi: 10.1097/CAD.0b013e3283300a29. Anticancer Drugs. 2010. PMID: 19823076

3

Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates.

Poupon MF, Arvelo F, Goguel AF, Bourgeois Y, Jacrot M, Hanania N, Arriagada R, Le Chevalier T. Poupon MF, et al. Among authors: bourgeois y. J Natl Cancer Inst. 1993 Dec 15;85(24):2023-9. doi: 10.1093/jnci/85.24.2023. J Natl Cancer Inst. 1993. PMID: 7902445

4

Response of a multidrug-resistant human small-cell lung cancer xenograft to chemotherapy.

Arvelo F, Poupon MF, Goguel AF, Lizard G, Bourgeois Y, Arriagada R, Le Chevalier T. Arvelo F, et al. Among authors: bourgeois y. J Cancer Res Clin Oncol. 1993;120(1-2):17-23. doi: 10.1007/BF01200719. J Cancer Res Clin Oncol. 1993. PMID: 7903668

5

Src kinase contributes to the metastatic spread of carcinoma cells.

Boyer B, Bourgeois Y, Poupon MF. Boyer B, et al. Among authors: bourgeois y. Oncogene. 2002 Apr 4;21(15):2347-56. doi: 10.1038/sj.onc.1205298. Oncogene. 2002. PMID: 11948418

6

A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression.

Jouanneau J, Moens G, Bourgeois Y, Poupon MF, Thiery JP. Jouanneau J, et al. Among authors: bourgeois y. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):286-90. doi: 10.1073/pnas.91.1.286. Proc Natl Acad Sci U S A. 1994. PMID: 7506417 Free PMC article.

7

Mitochondria-bound hexokinase as target for therapy of malignant gliomas.

Oudard S, Poirson F, Miccoli L, Bourgeois Y, Vassault A, Poisson M, Magdelénat H, Dutrillaux B, Poupon MF. Oudard S, et al. Among authors: bourgeois y. Int J Cancer. 1995 Jul 17;62(2):216-22. doi: 10.1002/ijc.2910620218. Int J Cancer. 1995. PMID: 7622299

8

[Drug sensitivity of bronchial small cell cancers transplanted to nude mice. Expression of the mdr1 gene and correlation with clinical practice. Effects of antagonists].

Poupon MF, Arvelo F, Bourgeois Y, Jacrot M. Poupon MF, et al. Among authors: bourgeois y. Bull Cancer. 1994 Dec;81 Suppl 2:86s-87s. Bull Cancer. 1994. PMID: 7727867 French. No abstract available.

9

Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.

Berlion M, Arvelo F, Leonce S, Bourgeois Y, Rigaudy P, Bizzari JP, Poupon MF. Berlion M, et al. Among authors: bourgeois y. In Vivo. 1993 Sep-Oct;7(5):399-405. In Vivo. 1993. PMID: 7906553

10

Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6.

Prévost G, Bourgeois Y, Mormont C, Lerrant Y, Veber N, Poupon MF, Thomas F. Prévost G, et al. Among authors: bourgeois y. Life Sci. 1994;55(2):155-62. doi: 10.1016/0024-3205(94)90107-4. Life Sci. 1994. PMID: 8015359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters